Elevated low-density lipoprotein cholesterol levels and prostate cancer risk: UK Biobank evidence - Takeaways - MDSpire

Elevated low-density lipoprotein cholesterol levels and prostate cancer risk: UK Biobank evidence

  • By

  • Alexa, R.

  • Kranz, J.

  • Thöne, M.

  • Grundl, S.

  • Hoffmann, M.

  • Koop, P. H.

  • Feng, C.

  • Schneider, K. M.

  • Schneider, C.

  • Saar, M.

  • February 27, 2026

  • 0 min

Share

  • 1

    Prostate cancer (PCa) is the second most common solid tumor in men globally, with complex associations involving hepatic function.

  • 2

    Research indicates that very low low-density lipoprotein (LDL) levels may paradoxically correlate with increased PCa incidence.

  • 3

    The UK Biobank study analyzed the relationship between lipid metabolism and PCa risk in a large cohort of over 500,000 participants.

  • 4

    Significant associations were found between family history of PCa, health index, and PCa risk, with elevated LDL showing a protective effect.

  • 5

    The study utilized multivariable Cox proportional hazards regression to assess various risk factors for PCa development.

Original Source(s)

Related Content